- Home
- STT vs IQV Comparison
STT vs IQV Comparison
Compare STT & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- IQV
- Stock Information
- Founded
- STT 1792
- IQV 1982
- Country
- STT United States
- IQV United States
- Employees
- STT N/A
- IQV N/A
- Industry
- STT Major Banks
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- STT Finance
- IQV Health Care
- Exchange
- STT Nasdaq
- IQV Nasdaq
- Market Cap
- STT 25.8B
- IQV 25.6B
- IPO Year
- STT N/A
- IQV 2013
- Fundamental
- Price
- STT $99.63
- IQV $154.78
- Analyst Decision
- STT Buy
- IQV Buy
- Analyst Count
- STT 13
- IQV 20
- Target Price
- STT $105.54
- IQV $226.80
- AVG Volume (30 Days)
- STT 1.6M
- IQV 2.3M
- Earning Date
- STT 07-15-2025
- IQV 07-21-2025
- Dividend Yield
- STT 3.05%
- IQV N/A
- EPS Growth
- STT 64.15
- IQV 0.26
- EPS
- STT 8.90
- IQV 7.35
- Revenue
- STT $13,086,000,000.00
- IQV $15,497,000,000.00
- Revenue This Year
- STT $4.63
- IQV $5.37
- Revenue Next Year
- STT $3.24
- IQV $5.19
- P/E Ratio
- STT $11.21
- IQV $21.12
- Revenue Growth
- STT 9.48
- IQV 2.84
- 52 Week Low
- STT $71.80
- IQV $134.65
- 52 Week High
- STT $103.00
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- STT 62.23
- IQV 55.12
- Support Level
- STT $96.16
- IQV $153.23
- Resistance Level
- STT $98.10
- IQV $159.85
- Average True Range (ATR)
- STT 1.61
- IQV 4.39
- MACD
- STT -0.15
- IQV 0.96
- Stochastic Oscillator
- STT 82.80
- IQV 67.09
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.